- Recent Funding
- Investors
- MRL Ventures Fund
MRL Ventures Fund portfolio
MRL Ventures Fund has 4 portfolio companies on record at Recent Funding.
About this page
It led 2 of the 8 rounds it joined. Its most recent investment on record is Therini Bio's $39M Series A round in May 2025, alongside Apollo Health Ventures, Eli Lilly, Dolby Family Ventures and 5 others. By category, its portfolio leans toward Health and bio (4) and Legal and compliance (1). It has co-invested with GV, ARCH Venture Partners and Blue Pool Capital, most often GV (3 rounds).
What MRL Ventures Fund invests in
- Health and bio · 4 · 100%
- Legal and compliance · 1 · 25%
- Data and analytics · 1 · 25%
MRL Ventures Fund recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Series A · $39M | Apollo Health Ventures, Eli Lilly, Dolby Family Ventures +5 | ||
| Series A · $57M · lead | EQT Life Sciences (lead), Sambrinvest, SFPIM +3 | ||
| Series B+ · $175M | 3W Partners Capital, ARCH Venture Partners, Fidelity Management & Research Company (lead) +4 | ||
| Series B+ · $100M | Monashee Investment Management, LSP BioVentures, SR One +6 | ||
| Seed · $17M · lead | Dolby Family Ventures, Foundation for a Better World, Sanofi Ventures (lead) +2 | ||
| Series B+ · $50M | Milky Way Investments (lead), ARCH Venture Partners, WuXi Healthcare Ventures +4 | ||
| Series B+ · $65M | Atlas Venture, SR One (lead), Solasta Ventures +3 | ||
| Series A · $55M | ARCH Venture Partners, WuXi Healthcare Ventures (lead), Blue Pool Capital +4 |
How MRL Ventures Fund invests
MRL Ventures Fund portfolio companies
TTherini Bio$39MSeries A · May 2025
AATB Therapeutics$57MSeries A · Dec 2024
LLifeMine Therapeutics$175MSeries B+ · Mar 2022
HHotSpot Therapeutics$100MSeries B+ · Nov 2021
| Company | Round with MRL Ventures Fund | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series A · $39M | $56M | May 21, 2026 Series A |
Health and bio |
Series A · $57M · lead | $57M | Dec 2, 2024 Series A |
Health and bio |
Series B+ · $175M | $543M | Aug 6, 2026 Series B+ |
Legal and compliance |
Series B+ · $100M | $210M | Nov 29, 2021 Series B+ |
Most frequent co-investors
GGV3 shared rounds · last Mar 23, 2022
AARCH Venture Partners3 shared rounds · last Mar 23, 2022
BBlue Pool Capital3 shared rounds · last Mar 23, 2022
SSanofi Ventures2 shared rounds · last May 19, 2025
SSV Health Investors2 shared rounds · last May 19, 2025
DDolby Family Ventures2 shared rounds · last May 19, 2025
FFoundation for a Better World2 shared rounds · last May 19, 2025
DDementia Discovery Fund2 shared rounds · last May 19, 2025
SSofinnova Partners2 shared rounds · last Nov 29, 2021
SSR One2 shared rounds · last Nov 29, 2021
TTekla Capital Management2 shared rounds · last Nov 29, 2021
FForesite Capital2 shared rounds · last Jan 7, 2021
Similar investors
AAble Partners4 companies · 1 deal in 12 mo
GGenoa Ventures5 companies · 4 deals in 12 mo
BBdc Thrive venture5 companies · 3 deals in 12 mo
BBpifrance Digital Venture5 companies · 3 deals in 12 mo
CCatalyst Health Ventures5 companies · 3 deals in 12 mo
NNPIF – Mercia Equity Finance5 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 8 rounds on Recent Funding that name MRL Ventures Fund. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists MRL Ventures Fund, which is a subset of its real portfolio. API: /api/v1/investors/mrl-ventures-fund (get a free API key). More: the most active VC firms and new venture capital funds.